Related Experiment Video
Updated: Dec 18, 2025
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2
Chiranjeevi Gadiparthi1, Abhilash Perisetti2, Hari Sayana3
1Division of Gastroenterology, Hepatology and Clinical Nutrition, Saint Peter's University Hospital, New Brunswick, New Jersey, USA.
Coronavirus Disease-2019 (COVID-19) patients frequently experience gastrointestinal symptoms. This case series explores the clinical implications and management challenges of gastrointestinal bleeding (GIB) in COVID-19 patients.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Critical Care Medicine
Background:
- Gastrointestinal symptoms are prevalent in COVID-19 patients.
- The association between SARS-CoV-2 infection and gastrointestinal bleeding (GIB) risk is not well-established.
- Managing GIB in COVID-19 presents unique challenges due to respiratory failure and airborne transmission risks during endoscopy.
Observation:
- This case series focuses on the clinical implications of managing GIB in the context of COVID-19.
Findings:
- The study aims to discuss critical aspects of GIB management in COVID-19 patients.
Implications:
- Understanding these challenges is crucial for optimizing patient care and procedural safety.
- Further research is needed to clarify the link between SARS-CoV-2 and GIB risk.
- This work highlights the need for tailored protocols for managing gastrointestinal emergencies during the pandemic.
More Related Videos
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:24Esophageal Varices-I: Introduction
01:28Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...